Patient was 62 at time of vaccination but given the dose approved for patients who are 65+, patient had no adverse reactions at the time of vaccination.
Patient was 62 at time of vaccination but given the dose approved for patients who are 65+, patient had no adverse reactions at the time of vaccination.